Mumbai, Jan. 27: The US Department of Justice has virtually hurled the book at Ranbaxy Industries as it filed a consent decree in the district court of Maryland as a first step towards resolving a four-year long investigation by the US Food and Drug Administration (FDA) that uncovered serious irregularities at the drug makers plants in India ... ...
Read the full story at
The Telegraph
